Liver transplant and portal vein blood clot study
Part of Blood & lymphatic, Digestive system clinical trials.
This study looks at how blood clots in the portal vein (the main vein to your liver) affect recovery and outcomes after a liver transplant. If you've had a liver transplant, your data may help doctors understand this better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have received a liver transplant
- You are 18 years old or older
- You have not had more than one liver transplant
- You did not receive a transplant of another organ at the same time
- You do not have a tumor-related clot in your portal vein
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks people with liver cirrhosis to see how often portal vein thrombosis (a blood clot in the main vein to the liver) occurs and how it can be treated with blood thinners. It aims to improve care for those at risk of these clots.
This study looks at factors that help open up blood clots in the main vein to the liver (portal vein) in people with cirrhosis and varices. It might help guide treatment to improve blood flow.
This trial compares two blood-thinning medications, dabigatran (a pill) and enoxaparin (a shot), to see which works better and is safer for people with cirrhosis who have a blood clot in the portal vein (the main vein to the liver). It may help prevent the clot from getting worse or causing complications.
This trial tests a procedure to lower blood loss during liver transplant for patients with high blood pressure in the liver. It may help those who have had a previous transplant, abdominal surgery, or certain complications of liver disease.
This trial explores using smaller liver grafts in a partial transplant to treat portal hypertension, which may help patients avoid full transplant risks. It compares this approach to standard liver transplant.
This study is for people with severe liver cirrhosis who are getting a liver transplant from a living donor. It looks at the risk of bleeding or clotting problems after the transplant, to help doctors better manage these risks.
Hear when a new Portal Vein Thrombosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.